Celestica director reports 267 new director share units on Form 4
Celestica Inc. director reports acquisition of additional director share units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Celestica Inc. director reports acquisition of additional director share units. A board member of Celestica Inc. (CLS) filed a Form 4 disclosing that on 12/31/2025 they acquired 267 director share units. These units carry no exercise price and represent the right to receive an equal number of common shares, or an equivalent cash amount, when the holder stops serving Celestica as a director, consultant or other service provider, at the company’s discretion. Following this transaction, the reporting person beneficially owns 1,116 derivative securities (director share units) on a direct basis.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Share Units | 267 | $0.00 | $0.00 |
Footnotes (1)
- F1. Each director share unit represents a contingent right to receive one common share or an equivalent value in cash at the Issuer's discretion when the holder ceases to serve the Issuer as any of a director, consultant or other service provider.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Celestica Inc. (CLS) disclose in this Form 4?
Is the Celestica Inc. (CLS) Form 4 filed for one reporting person or multiple?
What is the relationship of the reporting person to Celestica Inc. (CLS)?
AI-generated analysis. How Rhea-AI works. Not financial advice.